July 8, 2025 /

Approved Therapies & Sequential Therapy – PPMD 2025 Annual Conference

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

Approved Drugs and Sequential Therapy:

Discussing Catalyst Pharmaceuticals, ITF Therapeutics, NS Pharma, PTC Therapeutics, Sarepta Therapeutics

Moderator: Eric Camino, PhD

Leigh Ramos-Platt, MD

Aravindhan Veerapandiyan, MD

Larry Markham, MD, FAAP, FACC

Sam Mackenzie, MD, PhD

Craig McDonald, MD

2025 PPMD Annual Conference,
Conferences & Meetings

Join Our Mailing List

BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo